ArticleFrontiers in genetics2022

Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy.

Zhengjun Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.